Fatal liver failure after corticosteroid treatment of a hepatitis B virus carrier;Letales leberversagen nach corticosteroidtherapie bei hepatitis-B- carrier-status

Deutsche Medizinische Wochenschrift

Volumn 124, Issue 22, 1999, Pages 687-690

  Hammond, Angela ^a   Ramersdorfer, Christiane ^a   Palitzsch, Klaus Dieter ^a   Schölmerich, Jürgen ^a   Lock, Guntram ^a  

^a Klin und Poliklin F Inn Med I   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B(E) ANTIBODY; IMMUNOGLOBULIN M; LAMIVUDINE; STEROID; VIRUS DNA;

AGED; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD TRANSFUSION; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORTICOSTEROID THERAPY; DIABETES MELLITUS; HEPATITIS B VIRUS; HUMAN; ISCHEMIC HEART DISEASE; JAUNDICE; LIVER FAILURE; MALE; REMISSION; TREATMENT INDICATION; TREATMENT PLANNING; ULCERATIVE COLITIS; VIRUS CARRIER; VIRUS REACTIVATION;

EID: 0033523032     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1024398     Document Type: Article

References (20)

1. 1 Bain, V. G., N. M. Kneteman, K. Gutfreund, J. A. Shapiro, K. Fisher, G. Tipples, H. Lee, L. D. Jewell, D. L. Tyrell: Efficacy of lamivudine in chronic hepatitis B patients with active viral replication and decompensated cirrhosis undergoing liver transplantation. Transplantation 62(1996), 1456-1462.
2. 2 Caselitz, M., H. Link, R. Hein, H. Maschek, K. Böker, H. Poliwoda, M. P. Manns: Hepatitis B associated liver failure following bone marrow transplantation. J. Hepatol. 27(1997), 572-577.
3. 3 Dienstag, J. L., R. P. Perillo, E. R. Schiff, M. Bartholomew, C. Vicary, M. Rubin: A preliminary trial of lamivudine for chronic hepatitis B infection. New Engl. J. Med. 33(1995), 1657-1661.
4. 4 Galbraith, R. M., A. L. W. F. Eddleston, R. Williams, A. J. Zuckerman: Fulminant hepatic failure in leukaemia and choriocarcinoma related to withdrawal of cytotoxic drug therapy. Lancet 20 (1975), 528-530.
5. 5 Honkoop, P., R. A. de Man, P. E. Zondervan, S. W. Schalm: Histological improvement in patients with chronic hepatitis B virus infection treated with lamivudine. Liver 17 (1997), 103-106.
6. 6 Hoofnagle, J. H., A. M. di Bisceglie, J. G. Waggoner, Y. Park: Interferon alpha for patients with clinically apparent cirrhosis due to chronic hepatitis B. Gastroenterology 104(1993), 1116-1121.
7. 7 Hoofnagle, J. H., D. Lau: New therapies for hepatitis B. J. Viral. Hepat. 4 Suppl. 1 (1997), 41-50.
8. 8 Koga, Y., R. Kumashiro, K. Yasumoto, S. Shakado, N. Ono, H. Noguchi, K. Nagata, M. Sata, H. Abe, N. Kaku, K. Tanikawa: Two fatal cases of hepatitis B virus carriers after corticosteroid therapy for bronchial asthma. Intern. Med. 31 (1992), 208-213.
9. 9 Krogsgaard, K.: Does corticosteroid pretreatment enhance the effect of alpha interferon treatment in chronic hepatitis? J. Hepatol. 26 (1994), 159-162.
10. 10 Kumada, K., M. Mizokami, E. Orito, N. Kamejima, M. Yamamoto, Y. Tokuda, K. Suzuki, M. Narita, M. Mizuno: A case of HBsAg positive liver cirrhosis who died after withdrawal of steroids. (Abstract). Kansenshogaku-Zasshi. 66(1992), 99-103.
11. 11 Lee, W. M.: Hepatitis B virus infection. New Engl. J. Med. 337(1997), 1733-1745.
12. 12 Lok, A. S. F., P. C. Wu, C. I. Lai: A controlled trial of interferon with or without prednisone priming for chronic hepatitis B, Gastroenterology 102(1992), 2091-2097.
13. 13 Nair, P. V., M. J. Tong, D. Stevenson, D. Roskamp, C. Boone: Effects of short-term, high-dose prednisone treatment of patients with HBsAg-positive chronic active hepatitis. Liver 5 (1985), 8-12.
14. 14 Perrillo, R., E. R. Schiff, G. L. Davis, H. C. Bodenheimer, K. Lindsay, J. Payne, J. L. Dienstag, C. O'Brian, C. Tamburro, I. M. Jacobson, R. Sampilner, D. Feit, J. Lefkowitch, M. Kuhns, C. Meschievitz, B. Sanghvi, J. Albrecht, A. Gibas and the Hepatitis Interventional Therapy Group. A randomized controlled trial of IFN alpha 2 b alone and after prednisone withdrawal in the treatment of chronic hepatitis B. New Engl. J. Med. 323 (1990), 295-301.
15. 15 Perrillo, R., C. Tamburro, F. Regenstein: Low dose, titrable interferon alpha in decompensated liver disease caused by chronic infection with hepatitis B virus. Gastroenterology 109(1995), 908-916.
16. 16 Rakela, J., A. G. Redeker, B. Weliky: Effect of short-term prednisone therapy on aminotransferase levels and hepatitis B virus marker in chronic type B hepatitis. Gastroenterology 84(1983), 956-960.
17. 17 Scullard, G. H., C. I. Smith, T. C. Merigan, W. S. Robinson, P. B. Gregory: Effects of immunosuppressive therapy on viral markers in chronic active Hepatitis B. Gastroenterology 81(1981), 987-991.
18. 13 Thung, S. N., M. A. Geber, F. Klion, H. Gilbert: Massive hepatic necrosis after chemotherapy withdrawal in a hepatitis B virus carrier. Arch. intern. Med. 145 (1985), 1313-1314.
19. 19 Tygstrup, N., P. Krag Andersen, E. Juhl and the Trial group of the European Association for the study of the liver. Steroids in chronic B-hepatitis. A randomized, double-blind, multinational trial on the effect of low-dose, long-term treatment on survival. Liver 6(1986), 227-232.
20. 20 Villeneuve, J. P., M. Desrochers, C. Infante-Rivard, B. Willems, G. Raymond, M. Bourvier, J. Côté, R. Richer: A long-term-follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal. Gastroenterology 106(1994), 1000-1005.